Hotline:400-8201-126 中文 | English

Aims to become a giant in the global blood products industry

The designated media for information disclosure: "Securities Times", "China Securities Daily", "Shanghai Securities News", "Securities Daily".

Investor relations management contact: The Board Secretary: Liu Zheng

Securities affairs representative: Zhang Yi

Tel: 021-22130888

Fax: 021-64626161

Mail box:

Interactive platform:

Contact address: No.2009, Wangyuan Road, Fengxian District, Shanghai

Links:Tonrol Bio-Pharmaceutical Co., Ltd.,

Internet drug information service certificate :( Shanghai) Non-operating 2011-0201  Copyright © 2013-2014 Shanghai RAAS   All rights reserved  Powered by Yongsy